PEOPLE - Aureon Biosciences makes appointment:
This article was originally published in Clinica
Predictive testing specialist Aureon Biosciences (Yonkers, New York) has appointed Vijay Aggarwal as president and CEO, and named recently-appointed director Kevin Johnson as chairman. Aureon, a CLIA-certified diagnostics laboratory, develops predictive testing for personalised cancer clinical care. Its first test will be for prostate cancer, the most commonly-diagnosed non-skin cancer in the US. It will be launched in 2005.